148 related articles for article (PubMed ID: 37905661)
1. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
3. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
4. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.
Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB
Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.
Chen L; Hao Y; Cong X; Zou M; Li S; Zhu L; Song H; Xue Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819829485. PubMed ID: 30760114
[TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
8. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Otani K; Sawazaki S; Cho H; Morita J; Kawahara S; Tanabe M; Yukawa N; Saito A; Ogata T; Rino Y; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):402-409. PubMed ID: 37889434
[TBL] [Abstract][Full Text] [Related]
11. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
Kim EY; Lee JW; Yoo HM; Park CH; Song KY
Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235
[TBL] [Abstract][Full Text] [Related]
12. After neoadjuvant chemotherapy platelet/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients.
Gong W; Zhao L; Dong Z; Dou Y; Liu Y; Ma C; Qu X
J Clin Lab Anal; 2018 Jun; 32(5):e22364. PubMed ID: 29251364
[TBL] [Abstract][Full Text] [Related]
13. Value of Preoperative Hematological Parameters in the Prognosis of Gastric Cancer Patients Undergoing a Total Gastrectomy.
Zhu XS; Zhao Y; Ma FY; Wu SK
Curr Med Sci; 2022 Apr; 42(2):348-356. PubMed ID: 35419673
[TBL] [Abstract][Full Text] [Related]
14. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
Zhang LX; Wei ZJ; Xu AM; Zang JH
Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
[TBL] [Abstract][Full Text] [Related]
15. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer].
Li S; Xu X; Liang D; Tian G; Song S; He Y
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):910-5. PubMed ID: 25623765
[TBL] [Abstract][Full Text] [Related]
17. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
18. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
19. Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.
Wang Y; Xu F; Pan J; Zhu Y; Shao X; Sha J; Wang Z; Cai Y; Liu Q; Dong B; Xue W; Huang Y
BMC Cancer; 2016 May; 16():329. PubMed ID: 27222030
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]